Tyler’s Law
- Sponsor
- Rep. Lieu, Ted [D-CA-36]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Sep 16, 2026
Bottom line
Tyler's Law mandates a federal study and subsequent guidance on the routine implementation of fentanyl testing in hospital emergency departments for overdose patients.
What it actually does
This bill directs the Secretary of Health and Human Services (HHS) to conduct a study within one year on fentanyl testing practices in hospital emergency departments for overdose patients. Following the study, HHS is mandated to issue guidance within six months on whether routine fentanyl testing should be implemented, how hospitals can ensure clinicians are aware of tested substances, and the impact of such testing on future overdose risk and health outcomes.
Proponents argue
Supporters argue that this bill is a crucial step in addressing the ongoing fentanyl crisis by providing data-driven guidance to healthcare providers. They contend that understanding current testing practices, costs, benefits, and risks will lead to more informed decisions, potentially improving patient care, reducing overdose risks, and enhancing the patient-physician relationship through better information.
Opponents contend
Critics might express concerns that mandating a study and guidance could lead to unfunded mandates for hospitals if the guidance recommends routine testing without corresponding federal funding. They may also argue about potential administrative burdens on healthcare systems and the need to carefully balance patient privacy with the benefits of comprehensive testing, suggesting that the focus should remain on immediate treatment and long-term recovery support.
The bill is very short and clear, making it highly accessible for a quick read and understanding of its core directives.
Section 2(a)
Study on Fentanyl Testing in Emergency Departments
This provision directs the Secretary of Health and Human Services (HHS) to conduct a comprehensive study within one year of the bill's enactment. The study must investigate how frequently hospital emergency departments currently test for fentanyl during overdose cases, the associated costs, potential benefits and risks for patients, and the impact on patient experience, including confidentiality, privacy, and the patient-physician relationship.
Supporters argue
Supporters argue that this study is essential for gathering critical data on fentanyl testing, which is currently inconsistent across emergency departments. They believe that a thorough understanding of the current landscape, costs, and patient impacts is a necessary precursor to developing effective, evidence-based policies to combat the opioid crisis.
Critics contend
No specific opposition is typically raised against the concept of conducting a study to gather information. However, some might express concern about the scope or potential administrative burden of data collection on hospitals, or the timeliness of the study given the urgency of the fentanyl crisis.
Tradeoffs
The provision balances the need for comprehensive data to inform policy with the time and resources required to conduct a thorough study. It also seeks to balance the benefits of increased testing with patient privacy concerns.
Section 2(b)
Guidance on Fentanyl Testing Implementation
Following the completion of the study mandated in subsection (a), the Secretary of HHS is directed to issue guidance within six months. This guidance will address whether hospital emergency departments should routinely implement fentanyl testing for overdose patients, how hospitals can ensure clinicians are aware of all substances included in routinely administered drug tests, and how fentanyl testing might influence future overdose risks and overall health outcomes for patients.